Breaking Down the Latest Financial Results and Business Update from Molecular Templates Inc. – A Must-Read for Forex Traders!
Molecular Templates, Inc. Reports Strategic Reprioritization Focus on Clinical Development Molecular Templates, Inc. has announced a strategic reprioritization to focus on the clinical development of MT-6402, MT-8421, and MT-0169, as well as preclinical activities related to a collaboration with BMS. The company, based in Austin, Texas, is a clinical-stage biopharmaceutical company that specializes in the…